IXHL
Incannex Healthcare Inc.
$3.38
-0.33 (-8.89%)
At close · Jul 8
Market Cap
$40.44M
Shares
11,964,554
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.38
Open$3.64
Day$3.30–3.66
52W$2.49–49.80
Avg vol 30d312K
Short int770K · 6.4% float · 2.2d
Short vol70%
DataMar 2022–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−57%
below
Price vs 50-day avg
−10%
below
RSI (14)
45
neutral
MACD trend
Positive
52-week position
2%
near low
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−70%
trailing
YTD return
−69%
this year
Relative strength
−78%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.43% of float · ▼ -7.8% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Squeeze score
53
elevated · 0–100
Fundamentals
EPS growth
−17%
Y/Y
Free cash flow
$-12.5M
Balance sheet
$15.0M
net cash
Quant / Vol
risk profile
Volatility
179%
annualized · 1-yr
Max drawdown
−95%
past year
ATR
10.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−57%
Bearish
Price vs 50-day avg
−10%
Bearish
RSI (14)
45
Neutral
MACD trend
Positive
Bullish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $4 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.43% of float · ▼ -7.8% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $3 · 2%
52-wk high $50
vs 200-day avg -57%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IXHL
this stock
Incannex Healthcare Inc.
|
$40.44M | -68.5% | — | — | 6.4% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.04B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.76B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IXHL | -10.1% | -0.6% | -70.4% | -10.1% | -68.5% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -9.9% | -1.4% | -77.9% | -9.9% | -77.8% |